Accéder directement au contenu

Olivier Colliot

Olivier Colliot - Research Director at CNRS - ARAMIS Lab at the Paris Brain Institute (CNRS/Inria/Inserm/Sorbonne Universite)
16
Documents
Identifiants chercheurs
Contact

Présentation

Research Director at [CNRS](http://www.cnrs.fr/) Head of the [ARAMIS Lab](http://www.aramislab.fr/), a joint team between [CNRS](http://www.cnrs.fr/), [Inria](http://www.inria.fr/), [Inserm](http://www.inserm.fr/) and [University Pierre and Marie Curie](http://www.upmc.fr/) at the [Paris Brain Institute (ICM)](http://www.icm-institute.org/), in co-direction with Stanley Durrleman. Homepage: <https://www.aramislab.fr/perso/colliot/> Email: olivier.colliot@cnrs.fr
Research Director at [CNRS](http://www.cnrs.fr/) Head of the [ARAMIS Lab](http://www.aramislab.fr/), a joint team between [CNRS](http://www.cnrs.fr/), [Inria](http://www.inria.fr/), [Inserm](http://www.inserm.fr/) and [University Pierre and Marie Curie](http://www.upmc.fr/) at the [Paris Brain Institute (ICM)](http://www.icm-institute.org/), in co-direction with Stanley Durrleman. Homepage: <https://www.aramislab.fr/perso/colliot/> Email: olivier.colliot@cnrs.fr

Domaines de recherche

Intelligence artificielle [cs.AI] Imagerie médicale Apprentissage [cs.LG] Traitement des images [eess.IV]

Publications

harald-hampel
Image document

Accuracy of MRI Classification Algorithms in a Tertiary Memory Center Clinical Routine Cohort

 Alexandre Morin , Jorge Samper-González , Anne Bertrand , Sebastian Ströer , Didier Dormont
Journal of Alzheimer's Disease, 2020, pp.1-10. ⟨10.3233/JAD-190594⟩
Article dans une revue hal-02511532v1
Image document

Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease

 Patrizia A Chiesa , Enrica Cavedo , Andrea Vergallo , Simone Lista , Marie-Claude Potier
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2019, 15 (7), pp.940-950. ⟨10.1016/j.jalz.2019.03.006⟩
Article dans une revue hal-02368904v1
Image document

Reduction of recruitment costs in preclinical AD trials. Validation of automatic pre-screening algorithm for brain amyloidosis

 Manon Ansart , Stéphane Epelbaum , Geoffroy Gagliardi , Olivier Colliot , Didier Dormont
Statistical Methods in Medical Research, 2019, pp.096228021882303. ⟨10.1177/0962280218823036⟩
Article dans une revue hal-01964942v2
Image document

Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology

 Harald Hampel , Nicola Toschi , Claudio Babiloni , Filippo Baldacci , Keith L Black
Journal of Alzheimer's Disease, 2018, 64 (s1), pp.S47 - S105. ⟨10.3233/jad-179932⟩
Article dans une revue hal-01910402v1
Image document

Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study

 Bruno Dubois , Stéphane Epelbaum , Francis Nyasse , Hovagim Bakardjian , Geoffroy Gagliardi
The Lancet Neurology, 2018, 17 (4), pp.335 - 346. ⟨10.1016/S1474-4422(18)30029-2⟩
Article dans une revue hal-01777834v1
Image document

Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease

 Enrica Cavedo , Michel J Grothe , Olivier Colliot , Simone Lista , Marie Chupin
Scientific Reports, 2017, 7 (1), pp.11706. ⟨10.1038/s41598-017-09780-3⟩
Article dans une revue hal-01589622v1
Image document

Amyloidosis and neurodegeneration result in distinct structural connectivity patterns in mild cognitive impairment

 Thomas Jacquemont , Fabrizio de Vico Fallani , Anne Bertrand , Stéphane Epelbaum , Alexandre Routier
Neurobiology of Aging, 2017, ⟨10.1016/j.neurobiolaging.2017.03.023⟩
Article dans une revue hal-01518785v1

Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease

 Stefan J Teipel , Enrica Cavedo , Michel J Grothe , Simone Lista , Samantha Galluzzi
Neuropharmacology, 2016, 108, pp.128-35. ⟨10.1016/j.neuropharm.2016.02.005⟩
Article dans une revue hal-01372417v1
Image document

Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer’s Disease

 Enrica Cavedo , Bruno Dubois , Olivier Colliot , Simone Lista , Bernard Croisile
Journal of Clinical Psychiatry, 2016, ⟨10.4088/JCP.15m10413⟩
Article dans une revue hal-01388951v1

Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease

 Bruno Dubois , Marie Chupin , Harald Hampel , Simone Lista , Enrica Cavedo
Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2015, 11 (9), pp.1041-1049. ⟨10.1016/j.jalz.2014.10.003⟩
Article dans une revue hal-01249861v1

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020

 Harald Hampel , Simone Lista , Stefan J Teipel , Francesco Garaci , Robert Nisticò
Biochemical Pharmacology, 2014, pp.426-49
Article dans une revue hal-01098832v1
Image document

The road ahead to cure Alzheimer’s disease: development of biological markers and neuroimaging methods for prevention trials across all stages and target populations

 Enrica Cavedo , Simone Lista , Zaven S Khachaturian , Paul S Aisen , Philippe Amouyel
The Journal of prevention of Alzheimer's disease, 2014, 1 (3), pp.181-202. ⟨10.14283/jpad.2014.32⟩
Article dans une revue hal-01098836v1

Accuracy of MRI classification algorithms in a tertiary memory center clinical routine cohort

 Alexandre Morin , Jorge Samper-Gonzales , Anne Bertrand , Enrica Cavedo , Simone Lista
AAIC 2017 - Alzheimer's Association International Conference, Jul 2017, London, United Kingdom. pp.P772-P774, ⟨10.1016/j.jalz.2017.06.1034⟩
Communication dans un congrès hal-02192444v1
Image document

Prediction of amyloidosis from neuropsychological and MRI data for cost effective inclusion of pre-symptomatic subjects in clinical trials

 Manon Ansart , Stéphane Epelbaum , Geoffroy Gagliardi , Olivier Colliot , Didier Dormont
Multimodal Learning for Clinical Decision Support, Sep 2017, Quebec City, Canada
Communication dans un congrès hal-01578422v1
Image document

Selection of amyloid positive pre-symptomatic subjects using automatic analysis of neuropsychological and MRI data for cost effective inclusion procedures in clinical trials

 Manon Ansart , Stéphane Epelbaum , Olivier Colliot , Didier Dormont , Bruno Dubois
Clinical Trials for Alzheimer's Disease, Nov 2017, Boston, United States. pp.295
Communication dans un congrès hal-02098434v2

The INSIGHT cohort: baseline analysis of structural MR imaging in asymptomatic subjects at risk for Alzheimer's disease

 Anne Bertrand , Stephane Epelbaum , Marie-Odile Habert , Harald Hampel , Hovagim Bakardjian
AAIC, Jul 2016, Toronto, Canada. ⟨10.1016/j.jalz.2016.06.612⟩
Communication dans un congrès hal-01439571v1